– Scholarships will be awarded to up to 20 individuals living with Duchenne muscular dystrophy and up to five siblings of individuals living with Duchenne CAMBRIDGE, Mass., February 27, ...

The Federal Communications Commission voted Wednesday to advance sweeping reforms to its Lifeline program, tightening eligibility requirements and procedures for the nearly $3 billion phone and ...

The Fundamentals: Issues and Texts major admitted 32 students this past fall for its second-year cohort, more than doubling its third-year cohort of 14. The fourth-year cohort has 19 students. The ...

The JHipster team has shipped JHipster 9.0.0-beta.2, a follow-up to the project's first 9.0 beta, aimed squarely at improving generator stability while pushing the stack forward with Spring Boot 4.x.

The Council for the Indian School Certificate Examinations, CISCE will be conducting the ICSE Physics - Science Paper 1 Exam 2025 on Monday, March 17, 2025. The Physics paper will be held from 11 am ...

JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas — The United States Army World Class Athlete Program will be well-represented in the 2026 Winter Olympics from Feb. 6-22 in Milan-Cortina d’Ampezzo, ...

WASHINGTON — A measure that would ensure the 9/11 World Trade Center Health Program remains fully funded was approved by the U.S. House on Thursday, setting it up for a final vote in the U.S. Senate ...

Chef Im Sung Geun—who appeared on Netflix’s “Culinary Class Wars 2”—has revealed that he was convicted three times for drunk driving in the past. On January 18, Im Sung Geun confessed via his YouTube ...

OpenJDK project teams will focus work on features such as value types, code reflection, AOT compilation, and structured concurrency in the coming year. Oracle’s Java team in 2026 will work toward ...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases ...